[ @entity1968 and XXXX mixture in the topical treatment of several @entity272 (author's transl)].

@entity1 @entity2517 @entity24113 @entity10272 @entity8323 @entity272 @entity1968 @entity1487
The need for safe and effective topical treatments is underlined by several clinical trials over the years treating @entity272 with many and heterologous drugs, sometimes on a simple empirical basis. In a recent study Robinson and Kligman claimed to have obtained satisfactory results treating several cases of @entity2517 with an alternate regimen of @entity1968 and @entity1487 . We wish to report an open-label pilot study using a simple and readily accessible combination of commercially formulated and available agents as 0,05% @entity1968 cream and 5% @entity1487 cream over two groups of @entity1 . Treatment consisted of bid application of sparing amounts of an equal parts combination of @entity1968 and @entity1487 . The first group consisted of 7 @entity1 affected by @entity272 associated with an altered epidermal keratinization ( @entity2517 , @entity10272 , @entity24113 , phrynoderma and @entity8323 ). The @entity1 were followed up for a period of 15 to 60 days and, as it might be expected, the results were quite good. The second group, on the contrary, consisted of 6 @entity1 affected mainly by @entity272 involving the corium (LED, milium, colloid pseudomilium). The @entity1 were followed up for the same period of time as the first group was, but the results were much less rewarding. Only a partial resolution of the process, which was followed soon after by a relapse, was noted. Finally we believe that this modified regimen of equal parts of @entity1968 and @entity1487 has to be recommended in the topical treatment of the above mentioned @entity272 associated with an altered keratinization.
